Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.
about
Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts.Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinomaArginine dependence of tumor cells: targeting a chink in cancer's armor.TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.
P2860
Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Bioengineered arginase I incre ...... rgininosuccinate synthetase-1.
@en
Bioengineered arginase I incre ...... rgininosuccinate synthetase-1.
@nl
type
label
Bioengineered arginase I incre ...... rgininosuccinate synthetase-1.
@en
Bioengineered arginase I incre ...... rgininosuccinate synthetase-1.
@nl
prefLabel
Bioengineered arginase I incre ...... rgininosuccinate synthetase-1.
@en
Bioengineered arginase I incre ...... rgininosuccinate synthetase-1.
@nl
P2093
P2860
P1433
P1476
Bioengineered arginase I incre ...... argininosuccinate synthetase-1
@en
P2093
Katheryn L Massey
Steven A Curley
Warna D Kaluarachchi
P2860
P304
P356
10.1016/J.SURG.2010.03.022
P407
P577
2010-05-13T00:00:00Z